Form 8-K - Current report:
SEC Accession No. 0001193125-23-144564
Filing Date
2023-05-15
Accepted
2023-05-15 12:50:02
Documents
13
Period of Report
2023-05-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d427364d8k.htm   iXBRL 8-K 54159
2 EX-3.1 d427364dex31.htm EX-3.1 5520
  Complete submission text file 0001193125-23-144564.txt   186416

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ew-20230511.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ew-20230511_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ew-20230511_pre.xml EX-101.PRE 11256
7 EXTRACTED XBRL INSTANCE DOCUMENT d427364d8k_htm.xml XML 3471
Mailing Address ONE EDWARDS WAY IRVINE CA 92614
Business Address ONE EDWARDS WAY IRVINE CA 92614 9492502500
Edwards Lifesciences Corp (Filer) CIK: 0001099800 (see all company filings)

EIN.: 364316614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15525 | Film No.: 23920324
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies